Results 11 to 20 of about 114,570 (194)

Short-Term Clinical Outcomes of Packed Red Blood Cell Transfusions with Isolated Enzyme-Phase Crossmatch Incompatibility: A Single-Center Cross-Sectional Study

open access: yesTurkish Journal of Hematology, 2023
Acute hemolytic transfusion reactions (AHTRs) are feared complications of packed red blood cell (PRBC) transfusions. This study aimed to investigate the clinical consequences of isolated enzyme-phase crossmatch-incompatible PRBC transfusions by ...
Umut Yılmaz   +4 more
doaj   +2 more sources

Crossmatch incompatibility, indwelling experience from a single center, Bangladesh

open access: yesGlobal Journal of Transfusion Medicine, 2021
Background and Objectives: Crossmatch incompatibility among the blood donor and recipient is common. The cause for which may vary in patients despite rational transfusion practices.
Sonia Shormin Miah   +3 more
doaj   +2 more sources

HLA Antibody Incompatible Renal Transplantation: Long-term Outcomes Similar to Deceased Donor Transplantation [PDF]

open access: yesTransplantation Direct, 2021
Background. HLA incompatible renal transplantation still remains one of best therapeutic options for a subgroup of patients who are highly sensitized and difficult to match but not much is known about its long-term graft and patient survival.
Nithya Krishnan, MD, FRCP   +14 more
doaj   +2 more sources

Type and Screen Method versus Antihuman Globulin Crossmatch in Pretransfusion Testing: A Cross-sectional Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2023
Introduction: Blood transfusion remains the primary modality of treatment for many serious and common diseases. According to the International Society of Blood Transfusion (ISBT), there are about 349 blood group antigens, out of which only about 25-28
D UMESH   +3 more
doaj   +2 more sources

Accuracy of point‐of‐care crossmatching methods and crossmatch incompatibility in critically ill dogs [PDF]

open access: yesJournal of Veterinary Internal Medicine, 2021
Background The performance of commercial point‐of‐care crossmatch (CM) tests compared to laboratory tube agglutination CM is unknown. Additionally, there is limited information regarding CM incompatibility in ill dogs. Objectives To determine if point‐of‐
Hayden Marshall   +5 more
doaj   +3 more sources

First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients

open access: yesAsian Journal of Transfusion Science, 2017
Background and Objectives: The US Food and Drug Administration and American Association of Blood Banks approved the type and screen approach in 1980s, long after antibody screen (AS) was introduced in 1950s.
Aseem Kumar Tiwari   +5 more
doaj   +2 more sources

The least incompatible crossmatch red blood cell transfusion by biological compatibility test

open access: yesGlobal Journal of Transfusion Medicine, 2019
Introduction: Pretransfusion testing is an essential serological test to protect the recipient from hemolysis and provide compatible blood product. The final step is the crossmatching test which is done by the transfusion center.
Senem Maral   +5 more
doaj   +2 more sources

Anti-HLA Class II Antibodies Are the Most Resistant to Desensitization in Crossmatch-positive Living-donor Kidney Transplantations: A Patient Series [PDF]

open access: yesTransplantation Direct
Background. In HLA-incompatible kidney transplantation, the efficacy of desensitization in terms of anti-HLA antibody kinetics is not well characterized.
Annelies E. de Weerd, MD, PhD   +10 more
doaj   +4 more sources

Clinical evaluation of the endothelial tie-2 crossmatch in ABO compatible and ABO incompatible renal transplants

open access: yesHuman Immunology, 2013
The necessity of detection of other than the classical major histocompatibility complex (MHC) and MHC class I-related chain A (MICA) directed antibodies prior to organ transplantation has already been repeatedly reported. A commercial flow cytometric endothelial crossmatch (CM) using isolated peripheral blood tie-2 positive cells provides a tool to ...
Kafetzi, M.L.   +5 more
core   +5 more sources

Differences in Chronic Intragraft Inflammation Between Positive Crossmatch and ABO-Incompatible Kidney Transplantation

open access: yesTransplantation, 2014
ABO-incompatible kidney transplantations (ABOiKTxs) seem to have better long-term outcomes than positive crossmatch kidney transplantations (+XMKTxs).This study aimed to assess the differences in chronic injury on histologic findings on 1- and 5-year surveillance biopsies and the clinical outcomes in living-donor kidney transplantations performed ...
Andrew, Bentall   +8 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy